Prescription drug · ANDA
Oxaliplatin NDC 67184-0502
Oxaliplatin 100 mg/20mL · Injection, Powder, Lyophilized, For solution · Intravenous · Qilu Pharmaceutical Co., Ltd.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 67184-0502-1 | 6718405020167184050201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0502-1) / 20 mL in 1 VIAL, SINGLE-DOSEMarketed from May 11, 2016 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Oxaliplatin
- Generic name (nonproprietary)
- oxaliplatin
- Active ingredients
- Oxaliplatin — 100 mg/20mL
- Dosage form
- Injection, Powder, Lyophilized, For solution
- Route
- Intravenous
- Labeler
- Qilu Pharmaceutical Co., Ltd.NDC labeler code 67184
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204616
- Marketing start
- Listing expires
- Other FDA classes
- Platinum-containing Compounds (EXT)
- Identifiers
- Product ID 67184-0502_f9f54aa0-22e3-4958-b368-d89d716ac2faSPL ID f9f54aa0-22e3-4958-b368-d89d716ac2faSPL set ID e9e47f3c-9acc-44f5-b0bd-d26fe9d35d64RxCUI 1736784, 1736786UNII 04ZR38536JUPC 0367184050116, 0367184050215
- Pharmacologic class
- Platinum-based Drug
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N467184050201followed by a unit qualifier and the quantityPackage 67184-0502-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Oxaliplatin for Injection, USP, in combination with infusional fluorouracil and leucovorin, is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. treatment of advanced colorectal cancer. Oxaliplatin for Injection, USP is a platinum-based drug used in combination with infusional fluorouracil and leucovorin, which is indicated for: adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumor. ( 1 ) treatment of advanced colorectal cancer. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 67184-0502
- What is NDC 67184-0502?
- 67184-0502 is the product NDC for Oxaliplatin, Oxaliplatin 100 mg/20mL injection, powder, lyophilized, for solution, listed with the FDA by Qilu Pharmaceutical Co., Ltd.. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Oxaliplatin.
- What is the active ingredient?
- Oxaliplatin.
- Who is the labeler?
- Qilu Pharmaceutical Co., Ltd., NDC labeler code 67184. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Oxaliplatin?
- 39 other product NDCs are listed under this name. See all Oxaliplatin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Oxaliplatin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | Shandong New Time Pharmaceutical Co., Ltd. | 42677-336 | 42677-0336-10 |
| oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | Shandong New Time Pharmaceutical Co., Ltd. | 42677-337 | 42677-0337-10 |
| Oxaliplatin | Oxaliplatin 50 mg/10mL | Injection, Solution, ConcentrateIntravenous | Camber Pharmaceuticals, Inc. | 31722-357 | 31722-0357-10 |
| Oxaliplatin | Oxaliplatin 100 mg/20mL | Injection, Solution, ConcentrateIntravenous | Camber Pharmaceuticals, Inc. | 31722-358 | 31722-0358-20 |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | Apotex Corp. | 60505-6287 | 60505-6287-0260505-6287-04 |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-171 | 71288-0171-11 |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | Meitheal Pharmaceuticals Inc. | 71288-172 | 71288-0172-21 |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | Northstar Rx LLC | 72603-320 | 72603-0320-01 |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | Northstar Rx LLC | 72603-420 | 72603-0420-01 |
| Oxaliplatin | Oxaliplatin 5 mg/mL | Injection, SolutionIntravenous | BluePoint Laboratories | 68001-468 | 68001-0468-3668001-0468-37 |
Other NDCs under ANDA 204616
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Oxaliplatin | Oxaliplatin 50 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | Qilu Pharmaceutical Co., Ltd. | 67184-0501 |